Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Heidi Overton, Trump's nominee for FDA commissioner, faced tough questions at her Senate confirmation hearing, affirming that all FDA-approved vaccines — including the MMR shot — are "safe and effective." She sidestepped her past criticism of the abortion pill mifepristone and vowed to accelerate drug research to counter China's biotech rise. Her confirmation remains uncertain ahead of November midterms.
Heidi Overton, President Trump's pick to lead the FDA, faced a grilling at her Senate HELP Committee confirmation hearing on Sept. 24, navigating politically charged questions on vaccines, abortion, and U.S. drug innovation. When pressed by Committee Chairman Sen. Bill Cassidy (R-LA) — whose vote is critical — Overton affirmed that all FDA-approved vaccines, including the MMR shot, are "safe and effective," though she stopped short of explicitly saying Trump was wrong when he called the MMR vaccine "potentially quite lethal."
On mifepristone, Overton acknowledged the abortion pill has met FDA safety and efficacy standards but declined to "prejudge" an ongoing safety review — a notable shift from her earlier writings calling mail-access to the drug "dangerous." She also signaled support for FDA initiatives like "Operation Trialblazer" to speed early drug research and counter China's growing biotech influence.
Key Takeaways:
Why it matters: The FDA has been in turmoil — losing roughly 20% of its workforce and facing accusations of politicized decision-making under the previous commissioner. Overton's confirmation would shape the agency's direction on vaccines, reproductive health drugs, and biotech regulation at a pivotal moment for U.S. public health.
